Literature DB >> 9741551

Granulocytic sarcoma as isolated extramedullary relapse after donor lymphocyte infusion in a patient with CML who relapsed after allogeneic bone marrow transplantation: a case report.

J J Lee1, H J Kim, H Kook, I J Chung, J S Seo, K S Seo, T J Hwang.   

Abstract

Isolated granulocytic sarcoma (GS) has rarely been reported in a patient who underwent allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML). We report here a patient who developed an isolated GS after achieving hematologic and cytogenetic remission by donor lymphocyte infusion for the relapse of CML following BMT. The size of GS was slightly decreased after local irradiation of 1,500 cGy without further systemic chemotherapy or immunotherapy. He remained in hematologic and cytogenetic remission without systemic relapse of CML for 8 months. Thereafter, he died of sepsis. The appropriate treatment of GS and impact of its occurrence on prognosis following allogeneic BMT has yet to be determined.

Entities:  

Mesh:

Year:  1998        PMID: 9741551      PMCID: PMC3054431          DOI: 10.3346/jkms.1998.13.4.434

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  3 in total

1.  Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remission.

Authors:  Adam Kittai; Eun-Mi Yu; Imad Tabbara
Journal:  BMJ Case Rep       Date:  2014-12-23

2.  Clinicopathologic features and responses to radiotherapy of myeloid sarcoma.

Authors:  Wan-Yu Chen; Chun-Wei Wang; Chin-Hao Chang; Heng-Hsiu Liu; Keng-Hsueh Lan; Jih-Luh Tang; Hwei-Fang Tien; Sung-Hsin Kuo; Ann-Lii Cheng
Journal:  Radiat Oncol       Date:  2013-10-22       Impact factor: 3.481

3.  Bilateral Maxillary, Sphenoid Sinuses and Lumbosacral Spinal Cord Extramedullary Relapse of CML Following Allogeneic Stem Cell Transplant.

Authors:  Soudabeh Hosseini; Shahla Ansari; Parvaneh Vosough; Gholamreza Bahoush; Amir Ali Hamidieh; Bahram Chahardouli; Morteza Shamsizadeh; Mitra Mehrazma; Akbar Dorgalaleh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.